CDC Clarifies Ebola PPE Guidance for U.S. Healthcare Personnel
The Centers for Disease Control and Prevention (CDC) has clarified its guidance regarding personal protective equipment (PPE) for healthcare personnel caring for suspected and confirmed Ebola patients in U.S. healthcare facilities.
Based on feedback from healthcare facilities that have implemented the current guidance (originally posted October 2014), the guidance clarifies the use of fluid-resistant and impermeable gowns and coveralls. Specifications are provided in the guidance to assist facilities in selecting and ordering the recommended garments.
In addition to clarifying the specifications of gowns and coveralls recommended, the PPE guidance for confirmed Ebola patients is being updated with additional explanation, including:
• Expanding the rationale why respiratory protection is recommended when caring for an Ebola patient
• Clarifying that the trained observer should not serve as an assistant for taking off (doffing) PPE
• Suggesting that a designated doffing assistant or “buddy” might be helpful, especially in doffing with the Powered Air Purifying Respirator (PAPR) option;
• Modifying the PAPR doffing procedure to make the steps more clear
• Changing the order of boot cover removal. Boot covers are now removed after the gown or coverall
• Emphasizing the importance of frequent cleaning of the floor in the doffing area.
The updated PPE guidance for confirmed Ebola patients can be found on CDC’s website: http://www.cdc.gov/vhf/ebola/healthcare-us/ppe/guidance.html.
CDC’s PPE guidance for clinically stable persons under investigation for Ebola can be found here: http://www.cdc.gov/vhf/ebola/healthcare-us/ppe/guidance-clinically-stable-puis.html
The frequently asked questions page can be found here: http://www.cdc.gov/vhf/ebola/healthcare-us/ppe/faq.html
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
